FcRn regulates antigen presentation in dendritic cells downstream of DEC205-targeted vaccines
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
FcRn regulates antigen presentation in dendritic cells downstream of DEC205-targeted vaccines ; volume:9 ; number:1 ; day:9 ; month:4 ; year:2024 ; pages:1-12 ; date:12.2024
npj vaccines ; 9, Heft 1 (9.4.2024), 1-12, 12.2024
- Urheber
-
Macri, Christophe
Paxman, Matthew
Jenika, Devi
Lin, Xiao Peng
Elahi, Zahra
Gleeson, Paul A.
Caminschi, Irina
Lahoud, Mireille H.
Villadangos, Jose A.
Mintern, Justine D.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41541-024-00854-8
- URN
-
urn:nbn:de:101:1-2406241224523.974167690138
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Macri, Christophe
- Paxman, Matthew
- Jenika, Devi
- Lin, Xiao Peng
- Elahi, Zahra
- Gleeson, Paul A.
- Caminschi, Irina
- Lahoud, Mireille H.
- Villadangos, Jose A.
- Mintern, Justine D.
- SpringerLink (Online service)
Ähnliche Objekte (12)
The Role of FcRn in Antigen Presentation
Therapeutic dendritic cell cancer vaccines in hematologic malignancies
Research progress on dendritic cell vaccines in cancer immunotherapy
Novel vaccines targeting dendritic cells by coupling allergoids to mannan
Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
Effects of commonly used antiviral vaccines on human plasmacytoid dendritic cells
FaRN! FaRN
Cholesterol modified DP7 and pantothenic acid induce dendritic cell homing to enhance the efficacy of dendritic cell vaccines
Dendritic cell vaccines containing lymphocytes produce improved immunogenicity in patients with cancer
PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines
Specific microtubule-depolymerizing agents augment efficacy of dendritic cell-based cancer vaccines
RN
The Role of FcRn in Antigen Presentation
Therapeutic dendritic cell cancer vaccines in hematologic malignancies
Research progress on dendritic cell vaccines in cancer immunotherapy
Novel vaccines targeting dendritic cells by coupling allergoids to mannan
Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
Effects of commonly used antiviral vaccines on human plasmacytoid dendritic cells
FaRN! FaRN
Cholesterol modified DP7 and pantothenic acid induce dendritic cell homing to enhance the efficacy of dendritic cell vaccines
Dendritic cell vaccines containing lymphocytes produce improved immunogenicity in patients with cancer
PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines
Specific microtubule-depolymerizing agents augment efficacy of dendritic cell-based cancer vaccines
RN
The Role of FcRn in Antigen Presentation
Therapeutic dendritic cell cancer vaccines in hematologic malignancies
Research progress on dendritic cell vaccines in cancer immunotherapy
Novel vaccines targeting dendritic cells by coupling allergoids to mannan
Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
Effects of commonly used antiviral vaccines on human plasmacytoid dendritic cells
FaRN! FaRN
Cholesterol modified DP7 and pantothenic acid induce dendritic cell homing to enhance the efficacy of dendritic cell vaccines
Dendritic cell vaccines containing lymphocytes produce improved immunogenicity in patients with cancer
PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines
Specific microtubule-depolymerizing agents augment efficacy of dendritic cell-based cancer vaccines